We are live on ! Find out more
FC

Fore Capital Portfolio holdings

AUM $338M Turnover 62.67%
1-Year Est. Return 10.07%
This Fund
S&P 500
This Quarter Est. Return
+0.81%
1 Year Est. Return
+10.07%
3 Year Est. Return
+25.37%
5 Year Est. Return
+23.47%
10 Year Est. Return
–
AUM
$294M
AUM Growth
+$99.4M
Cap. Flow
-$48.6M
Cap. Flow %
-16.51%
Top 10 Hldgs %
77.87%
Holding
65
New
15
Increased
5
Reduced
5
Closed
20
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.7 years

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.06M
2
SHC icon
Sotera Health
SHC
+$1.32M
3
SLV icon
iShares Silver Trust
SLV
+$1.08M
4
SNY icon
Sanofi
SNY
+$989K
5
SILC icon
Silicom
SILC
+$931K

Top Sells

Rank Stock Value
1
XDIV icon
U.S. Equity Ex-Dividends Fund - Series 2027
XDIV
+$14.5M
2
T icon
AT&T
T
+$1.89M
3
OGN icon
Organon & Co
OGN
+$1.48M
4
EQT icon
EQT Corp
EQT
+$1.02M
5
EPD icon
Enterprise Products Partners
EPD
+$673K

Sector Composition

Rank Sector Weight
1 Miscellaneous 96.33%
2 Healthcare 1.64%
3 Technology 0.81%
4 Materials 0.39%
5 Utilities 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GLD icon
1
CALL
SPDR Gold Trust
GLD
$142B
$103M 34.87%
+600,000
New +$101M
2021 Q4
0 quarters
SLV icon
2
CALL
iShares Silver Trust
SLV
$27.9B
$46.2M 15.72%
2,150,000
-742,200
-26% -$16M
2017 Q4
16 quarters
HYG icon
3
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$34.8M 11.83%
+400,000
New +$34.7M
2021 Q4
0 quarters
EPD icon
4
CALL
Enterprise Products Partners
EPD
$76.8B
$8.56M 2.91%
390,000
+140,000
+56% +$3.14M
2021 Q3
1 quarter
WMB icon
5
CALL
Williams Companies
WMB
$84.7B
$7.81M 2.66%
300,000
+100,000
+50% +$2.76M
2021 Q3
1 quarter
SNY icon
6
CALL
Sanofi
SNY
$96.5B
$4.01M 1.36%
+80,000
New +$3.96M
2021 Q4
0 quarters
SILC icon
7
Silicom
SILC
$251M
$2.4M 0.81%
46,429
+21,000
+83% +$931K
2021 Q3
1 quarter
AZN icon
8
AstraZeneca
AZN
$259B
$2.04M 0.69%
+17,500
New +$2.06M
2021 Q4
0 quarters
MOS icon
9
CALL
The Mosaic Company
MOS
$6.02B
$1.97M 0.67%
+50,000
New +$1.91M
2021 Q4
0 quarters
IDIV
10
DELISTED
U.S. Equity Cumulative Dividends Fund - Series 2027
IDIV
$1.95M 0.66%
191,605
-8,395
-4% -$84.8K
2018 Q2
14 quarters
STNG icon
11
CALL
Scorpio Tankers
STNG
$4.15B
$1.54M 0.52%
+120,000
New +$1.85M
2021 Q4
0 quarters
CHTR icon
12
PUT
Charter Communications
CHTR
$12.6B
$1.3M 0.44%
+2,000
New +$1.36M
2021 Q4
0 quarters
WMB icon
13
PUT
Williams Companies
WMB
$84.7B
$1.3M 0.44%
50,000
-50,000
-50% -$1.38M
2021 Q3
1 quarter
SHC icon
14
Sotera Health
SHC
$5.16B
$1.29M 0.44%
+55,000
New +$1.32M
2021 Q4
0 quarters
AZN icon
15
CALL
AstraZeneca
AZN
$259B
$1.17M 0.4%
+10,000
New +$1.18M
2021 Q4
0 quarters
SLV icon
16
iShares Silver Trust
SLV
$27.9B
$1.08M 0.37%
+50,000
New +$1.08M
2021 Q4
0 quarters
SNY icon
17
Sanofi
SNY
$96.5B
$1M 0.34%
+20,000
New +$989K
2021 Q4
0 quarters
VST icon
18
Vistra
VST
$51.7B
$897K 0.3%
39,409
+3,000
+8% +$60.2K
2021 Q2
2 quarters
PLL icon
19
DELISTED
Piedmont Lithium
PLL
$787K 0.27%
+15,000
New +$878K
2021 Q4
0 quarters
PLL icon
20
PUT
DELISTED
Piedmont Lithium
PLL
$787K 0.27%
+15,000
New +$878K
2021 Q4
0 quarters
TE icon
21
T1 Energy
TE
$878M
$671K 0.23%
+60,000
New +$650K
2021 Q4
0 quarters
EPD icon
22
Enterprise Products Partners
EPD
$76.8B
$439K 0.15%
20,000
-30,000
-60% -$673K
2020 Q4
4 quarters
CCO icon
23
Clear Channel Outdoor Holdings
CCO
$1.23B
$435K 0.15%
131,524
– –
2018 Q1
15 quarters
TMQ icon
24
Trilogy Metals
TMQ
$444M
$373K 0.13%
225,766
+30,000
+15% +$55.3K
2020 Q4
4 quarters
BMRA icon
25
Biomerica
BMRA
$8.65M
$331K 0.11%
10,625
-6,250
-37% -$241K
2021 Q1
3 quarters
1
2

Similar funds

EWA
Etesian Wealth Advisors West Linn, Oregon $338M AUM 15.5% 1-Year Est. Return
ECAM
East Coast Asset Management Essex, Massachusetts $339M AUM 36.71% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $339M AUM 120.53% 1-Year Est. Return
NIWA
New Insight Wealth Advisors San Ramon, California $339M AUM 28.36% 1-Year Est. Return
HFS
Haverford Financial Services Radnor, Pennsylvania $339M AUM 16.41% 1-Year Est. Return
CWM
Castle Wealth Management West Palm Beach, Florida $338M AUM 18.79% 1-Year Est. Return
BAM
Brilliance Asset Management Admiralty, Hong Kong, Hong Kong $339M AUM 8.73% 1-Year Est. Return
JWM
Jeppson Wealth Management Manhattan Beach, California $339M AUM 32.85% 1-Year Est. Return

Fore Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Fore Capital held 65 positions worth $294M, up 51% from $195M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Fore Capital withdrew a net $48.6M in Q4 2021, closing 20 positions and reducing 5 holdings. Its most notable exit was U.S. Equity Ex-Dividends Fund - Series 2027, an estimated $14.5M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 95% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Fore Capital opened a new position in AstraZeneca worth $2.04M.

  • Fore Capital's largest Q4 2021 buy was AstraZeneca: 17,500 shares worth $2.04M.
  • Fore Capital added most to Silicom in Q4 2021, an estimated $931K increase.
  • Fore Capital's biggest Q4 2021 reduction was Enterprise Products Partners, cutting an estimated $673K.
  • Fore Capital fully exited U.S. Equity Ex-Dividends Fund - Series 2027 in Q4 2021, selling an estimated $14.5M.
  • Fore Capital's ten largest holdings make up 78% of its $294M portfolio in Q4 2021.
  • Fore Capital opened 15 new positions and closed 20 in Q4 2021.
  • Fore Capital's portfolio value rose 51% quarter-over-quarter to $294M.

Based on Fore Capital's 13F filing for Q4 2021, filed 11 Feb 2022.